Mercados españoles cerrados

GlaxoSmithKline plc (GSK)

NYSE - Nasdaq Precio en tiempo real. Divisa en USD
Añadir a la lista de favoritos
41,02+0,45 (+1,11%)
A partir del 1:40PM EDT. Mercado abierto.

GlaxoSmithKline plc

980 Great West Road
Brentford TW8 9GS
United Kingdom
44 20 8047 5000

SectorDrug Manufacturers—General
Empleados a tiempo completo94.066

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Ms. Emma N. WalmsleyCEO & Director3,89MN/A1970
Dr. Hal V. BarronChief Scientific Officer, Pres of R&D and Director4,83MN/A1963
Mr. Hasham BaberCFO & Exec. DirectorN/AN/AN/A
Ms. Karenann K. TerrellChief Digital & Technology OfficerN/AN/A1962
Ms. Sarah Elton-FarrHead of Investor RelationsN/AN/AN/A
Mr. Nick HironsSr. VP of Global Ethics & ComplianceN/AN/AN/A
Mr. James FordSr. VP & Gen. CounselN/AN/AN/A
Ms. Sally JacksonSr. VP of Global Communications & CEO OfficeN/AN/AN/A
Ms. Diana ConradSr. VP of HRN/AN/AN/A
Mr. David Simon RedfernChief Strategy OfficerN/AN/A1966
Los importes son a partir de 31 de diciembre de 2020 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.


GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc., and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Gobierno corporativo

El ISS Governance QualityScore de GlaxoSmithKline plc, a día 1 de junio de 2021, es 5. Las puntuaciones base son Auditoría: 1; Tablero: 3; Derechos de los accionistas: 1; Compensación: 8.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.